#Bicalutamide (#C18H14F4N2O4S) is a #medication used to treat prostate cancer. Its molecular structure includes a benzene ring, a fluorophenyl group, an amide functional group, and a sulfonamide functional group. The carbon atoms in the fluorophenyl group are sp2 hybridized, while those in the amide and sulfonamide groups are sp3 hybridized.